O	0	1	A
O	2	6	risk
O	7	12	score
O	13	16	for
O	17	20	the
O	21	31	prediction
O	32	34	of
B-Disease	35	43	advanced
I-Disease	44	47	age
I-Disease	47	48	-
I-Disease	48	55	related
I-Disease	56	63	macular
I-Disease	64	76	degeneration
O	76	77	:
O	78	89	development
O	90	93	and
O	94	104	validation
O	105	107	in
O	108	109	2
O	110	121	prospective
O	122	129	cohorts
O	129	130	.

O	132	134	To
O	135	142	develop
O	143	144	a
O	145	153	clinical
O	154	157	eye
O	157	158	-
O	158	166	specific
O	167	177	prediction
O	178	183	model
O	184	187	for
B-Disease	188	196	advanced
I-Disease	197	200	age
I-Disease	200	201	-
I-Disease	201	208	related
I-Disease	209	216	macular
I-Disease	217	229	degeneration
O	230	231	(
B-Disease	231	234	AMD
O	234	235	)
O	235	236	.

O	237	240	The
B-Classification_system	241	244	Age
I-Classification_system	244	245	-
I-Classification_system	245	252	Related
I-Classification_system	253	256	Eye
I-Classification_system	257	264	Disease
I-Classification_system	265	270	Study
O	271	272	(
B-Classification_system	272	277	AREDS
O	277	278	)
O	279	285	cohort
O	286	294	followed
O	295	297	up
O	298	301	for
O	302	303	8
O	304	309	years
O	310	316	served
O	317	319	as
O	320	323	the
O	324	332	training
O	333	340	dataset
O	340	341	,
O	342	345	and
O	346	349	the
O	350	354	Blue
O	355	364	Mountains
B-Anatomy	365	368	Eye
O	369	374	Study
O	375	376	(
O	376	380	BMES
O	380	381	)
O	382	388	cohort
O	389	397	followed
O	398	400	up
O	401	404	for
O	405	407	10
O	408	413	years
O	414	420	served
O	421	423	as
O	424	427	the
O	428	438	validation
O	439	446	dataset
O	446	447	.

O	448	449	A
O	450	455	total
O	456	458	of
O	459	463	4507
B-Classification_system	464	469	AREDS
O	470	482	participants
O	483	484	(
O	484	496	contributing
O	497	501	1185
O	502	510	affected
O	511	513	vs
O	513	514	.
O	515	519	6992
O	520	530	unaffected
B-Anatomy	531	535	eyes
O	535	536	)
O	537	540	and
O	541	545	2169
O	546	550	BMES
O	551	563	participants
O	564	565	(
O	565	577	contributing
O	578	580	69
O	581	589	affected
O	590	592	vs
O	592	593	.
O	594	598	3694
O	599	609	unaffected
B-Anatomy	610	614	eyes
O	614	615	)
O	615	616	.

O	617	622	Using
B-Diagnostic_tool	623	628	Bayes
I-Diagnostic_tool	628	629	'
I-Diagnostic_tool	630	637	theorem
I-Diagnostic_tool	638	640	in
I-Diagnostic_tool	641	642	a
I-Diagnostic_tool	643	651	logistic
I-Diagnostic_tool	652	657	model
O	657	658	,
O	659	661	we
O	662	666	used
O	667	668	8
O	669	677	baseline
O	678	688	predictors
O	688	689	-
B-Characteristic	689	692	age
O	692	693	,
B-Characteristic	694	697	sex
O	697	698	,
B-Characteristic	699	708	education
I-Characteristic	709	714	level
O	714	715	,
B-Characteristic	716	720	race
O	720	721	,
B-Characteristic	722	729	smoking
I-Characteristic	730	736	status
O	736	737	,
O	738	741	and
B-Symptom	742	750	presence
I-Symptom	751	753	of
I-Symptom	754	761	pigment
I-Symptom	762	773	abnormality
O	773	774	,
B-Symptom	775	779	soft
I-Symptom	780	786	drusen
O	786	787	,
O	788	791	and
B-Characteristic	792	799	maximum
I-Characteristic	800	806	drusen
I-Characteristic	807	811	size
O	811	812	-
O	812	814	to
O	815	821	devise
O	822	825	and
O	826	834	validate
O	835	836	a
B-Classification_system	837	844	macular
I-Classification_system	845	849	risk
I-Classification_system	850	857	scoring
I-Classification_system	858	864	system
O	865	866	(
B-Classification_system	866	870	MRSS
O	870	871	)
O	871	872	.

O	873	875	We
O	876	884	assessed
O	885	888	the
O	889	900	performance
O	901	903	of
O	904	907	the
B-Classification_system	908	912	MRSS
O	913	915	by
O	916	927	calculating
O	928	939	sensitivity
O	939	940	,
O	941	952	specificity
O	952	953	,
O	954	957	and
O	958	961	the
O	962	966	area
O	967	972	under
O	973	976	the
O	977	985	receiver
O	986	995	operating
O	996	1010	characteristic
O	1011	1016	curve
O	1017	1018	(
O	1018	1019	i
O	1019	1020	.
O	1020	1021	e
O	1021	1022	.
O	1022	1023	,
O	1024	1025	c
O	1025	1026	-
O	1026	1031	index
O	1031	1032	)
O	1032	1033	.

B-Disease	1034	1042	Advanced
I-Disease	1043	1046	AMD
O	1046	1047	.

O	1048	1051	The
O	1052	1062	internally
O	1063	1072	validated
O	1073	1074	c
O	1074	1075	-
O	1075	1085	indexAREDS
O	1086	1087	(
O	1087	1088	0
O	1088	1089	.
O	1089	1091	88
O	1091	1092	;
O	1093	1095	95
O	1095	1096	%
O	1097	1107	confidence
O	1108	1116	interval
O	1116	1117	,
O	1118	1119	0
O	1119	1120	.
O	1120	1122	87
O	1122	1123	-
O	1123	1124	0
O	1124	1125	.
O	1125	1127	89
O	1127	1128	)
O	1129	1132	and
O	1133	1136	the
O	1137	1147	externally
O	1148	1157	validated
O	1158	1159	c
O	1159	1160	-
O	1160	1169	indexBMES
O	1170	1171	(
O	1171	1172	0
O	1172	1173	.
O	1173	1175	91
O	1175	1176	;
O	1177	1179	95
O	1179	1180	%
O	1181	1191	confidence
O	1192	1200	interval
O	1200	1201	,
O	1202	1203	0
O	1203	1204	.
O	1204	1206	88
O	1206	1207	-
O	1207	1208	0
O	1208	1209	.
O	1209	1211	95
O	1211	1212	)
O	1213	1222	suggested
O	1223	1232	excellent
O	1233	1244	performance
O	1245	1247	of
O	1248	1251	the
B-Classification_system	1252	1256	MRSS
O	1256	1257	.

O	1258	1261	The
O	1262	1273	sensitivity
O	1274	1277	and
O	1278	1289	specificity
O	1290	1292	at
O	1293	1296	the
O	1297	1304	optimal
B-Characteristic	1305	1312	macular
I-Characteristic	1313	1317	risk
I-Characteristic	1318	1323	score
O	1324	1330	cutoff
O	1331	1336	point
O	1337	1339	of
O	1340	1341	0
O	1342	1346	were
O	1347	1349	87
O	1349	1350	.
O	1350	1351	6
O	1351	1352	%
O	1353	1356	and
O	1357	1359	73
O	1359	1360	.
O	1360	1361	6
O	1361	1362	%
O	1362	1363	,
O	1364	1376	respectively
O	1376	1377	.

O	1378	1380	An
O	1381	1392	application
O	1393	1396	for
O	1397	1400	the
O	1401	1407	iPhone
O	1408	1411	and
O	1412	1416	iPad
O	1417	1421	also
O	1422	1425	was
O	1426	1435	developed
O	1436	1438	as
O	1439	1440	a
O	1441	1450	practical
O	1451	1455	tool
O	1456	1459	for
O	1460	1463	the
B-Classification_system	1464	1468	MRSS
O	1468	1469	.

O	1470	1473	The
B-Classification_system	1474	1478	MRSS
O	1479	1482	was
O	1483	1492	developed
O	1493	1496	and
O	1497	1506	validated
O	1507	1509	to
O	1510	1517	provide
O	1518	1530	satisfactory
O	1531	1539	accuracy
O	1540	1543	and
O	1544	1560	generalizability
O	1560	1561	.

O	1562	1564	It
O	1565	1568	may
O	1569	1571	be
O	1572	1576	used
O	1577	1579	to
O	1580	1586	screen
O	1587	1595	patients
O	1596	1598	at
O	1599	1603	risk
O	1604	1606	of
O	1607	1617	developing
B-Disease	1618	1626	advanced
I-Disease	1627	1630	AMD
O	1630	1631	.
